The G20 India Presidency will hold a three-day Health Working Group meeting in Hyderabad starting on Sunday. The meeting will focus on the three main priorities of the G20 Health Track: health emergencies prevention, preparedness, and response; strengthening cooperation in the pharmaceutical sector; and digital health innovations. The side events will highlight research and innovation in the health sector, including pharma, vaccines, therapeutics, and diagnostics.
India’s G20 Presidency focuses on these priorities, with a focus on anti-microbial resistance and ‘One Health’ framework. The G20 Presidency presents a unique opportunity to address the concerns of the Global South. Collaboration with these priorities is being hosted for each health working group meeting that focuses on an emerging aspect in the health sector.
The 3rd Health Working Group Meeting will focus on Research and Development and Innovation in its side event. Besides, there will be a discussion on the theme of Finance and Health to identify the best practices and their integration to evolve a framework to deliver the right health solutions at the right time.
India has contributed significantly to addressing the global requirements. Lav Agarwal stated that “India has garnered in-principal agreement to the three proposed priorities and seeks to build global convergence on an agile, aligned global health architecture.”
The meeting will see participation from 180 members, 10 invited countries, and 22 international organizations. The side event will focus on deliberating on frameworks for research development and innovation for the creation of a network that would leverage access across the world. Additionally, there will also be a co-branded event on Global Vaccine Collaborative as well as a visit to Genome Valley, showcasing India’s prowess in research and development and pharmaceutical manufacturing.
